Intelligent Bio Solutions INBS Income Statement (2019-2025)

NASDAQ INBS
$2.65 -0.02 (-0.75%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025
Revenue & cost
Revenue (Quarter)
0.06M0.28M0.03M0.42M0.18M0.19M1.19M0.35M0.36M0.46M0.44M0.80M0.76M0.82M0.87M0.61M0.73M
Cost of Revenue (Quarter)
0.11M0.42M0.39M0.56M0.56M0.65M0.53M0.38M0.39M
Gross Profit (Quarter)
0.24M0.03M0.05M0.23M0.20M0.18M0.35M0.22M0.34M
Operating items
Research & Development (Quarter)
0.34M
Selling, General & Administrative (Quarter)
0.52M0.67M1.01M1.15M1.33M1.00M1.12M1.46M1.45M2.25M1.90M2.43M2.46M1.71M2.43M1.95M1.81M2.41M
Restructuring Costs (Quarter)
0.03M
Other Operating Expenses (Quarter)
0.20M0.19M2.16M1.31M0.11M2.64M0.41M0.69M0.05M0.40M4.80M0.36M0.41M0.64M0.79M1.25M0.81M0.66M
Operating Expenses (Quarter)
0.72M1.20M3.17M2.46M1.44M3.64M1.54M2.15M1.53M2.64M6.69M2.79M2.87M2.34M3.22M3.20M2.62M3.07M
Operating Income (Quarter)
-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M-2.81M-2.73M-2.26M-2.56M
EBIT (Quarter)
-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M-2.81M-2.73M-2.26M-2.56M
Non-operating items
Non Operating Investment Income (Quarter)
-0.14M1.79M0.27M0.09M0.13M0.04M
Interest & Investment Income (Quarter)
70.00434.000.01M0.01M0.00M0.00M0.00M0.00M0.01M0.00M508.0089.00139.000.00M0.01M0.05M0.02M0.02M
Other Non Operating Income (Quarter)
-0.19M-0.09M0.01M-892.00-0.00M14.0010.00-893.00-0.00M-0.01M0.01M-893.00-555.00-996.00-51.000.01M-113.00
Non Operating Income (Quarter)
-0.41M-1.07M-0.00M0.00M0.00M0.00M-0.00M-87.000.00M1.70M0.19M0.03M0.09M0.01M-0.03M0.02M0.03M0.01M0.01M
Net income details
EBT (Quarter)
-1.08M-1.99M-3.14M-0.85M-1.44M-3.46M-1.34M-8.15M-7.54M-10.28M-6.35M-12.23M-3.29M-2.79M-3.73M-13.23M-3.51M-3.03M-3.35M
Tax Provisions (Quarter)
1.96M3.39M-8.00M
Profit After Tax (Quarter)
-1.08M-1.99M-3.13M-0.57M-1.44M-3.46M-1.34M-2.03M-1.21M-0.43M-6.42M-10.81M-2.43M-1.98M-3.13M-2.71M-2.69M-2.26M-2.43M
Income from Non-Controlling Interests (Quarter)
-0.00M-0.01M-0.01M0.00M-0.01M-0.00M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M-0.01M
Income from Continuing Operations (Quarter)
-1.08M-3.95M-6.53M7.15M-1.44M-3.46M-1.34M-8.15M-7.54M-10.28M-6.35M-12.23M-3.29M-2.79M-3.73M-13.23M-3.51M-3.03M-3.35M
Consolidated Net Income (Quarter)
-1.08M-3.95M-6.53M7.15M-1.44M-3.46M-1.34M-8.15M-7.54M-10.28M-6.35M-12.23M-3.29M-2.79M-3.73M-13.23M-3.51M-3.03M-3.35M
Income towards Parent Company (Quarter)
-1.08M-3.95M-6.53M7.15M-1.44M-3.46M-1.34M-8.15M-7.54M-10.28M-6.35M-12.23M-3.29M-2.79M-3.73M-13.23M-3.51M-3.03M-3.35M
Net Income towards Common Stockholders (Quarter)
-1.08M-3.95M-6.53M7.15M-1.44M-3.46M-1.34M-8.15M-7.54M-10.28M-6.35M-12.23M-3.29M-2.79M-3.73M-13.23M-3.51M-3.03M-3.35M
Additional items
EPS (Basic) (Quarter)
-299.48-0.00M-0.00M0.00M-246.37-558.59-216.66-0.00M-0.00M-0.00M-687.52-0.00M-169.50-29.34-17.95-83.08-9.21-6.68-5.81
EPS (Diluted) (Quarter)
82.42-16.57-27.93-10.84-0.00M-0.00M-0.00M-687.52-0.00M-169.50-29.34-17.95-83.08-9.21-6.68-5.81
Shares Outstanding (Quarter)
0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.09M0.21M0.16M0.38M0.45M0.58M0.53M
Shares Outstanding (Diluted) (Quarter)
0.09M0.09M0.12M0.12M0.01M0.01M0.01M0.01M0.01M0.02M0.09M0.21M0.16M0.38M0.45M0.58M0.53M
Shares Outstanding (Entity) (Quarter)
0.00M0.00M0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.02M0.09M0.21M0.16M0.44M0.48M0.68M0.53M
EBITDA (Quarter)
-0.66M-0.92M-3.14M-0.85M-1.44M-3.47M-1.34M-2.09M-1.22M-2.13M-6.54M-2.70M-2.53M-1.99M-2.95M-2.81M-2.73M-2.26M-2.56M
Interest Expenses (Quarter)
0.09M0.91M5.00M7.22M6.46M7.51M6.06M6.33M8.15M7.60M9.53M0.77M0.80M0.79M10.42M0.84M0.79M0.81M0.86M
Tax Rate (Quarter)
-98.30%-107.87%941.31%